The Future of TAVR: Ensuring Safety and Efficacy for All Patients.
As the medical community continues to embrace Transcatheter Aortic Valve Replacement (TAVR), we are witnessing its widespread use among low-risk patients. While this advancement is promising, it raises important questions about the necessity for more comprehensive clinical trials and guidance tailored specifically for both low and high-risk patient populations.